FDA Inspection 1289250 — Biomat USA Inc
The FDA completed an inspection of Biomat USA Inc on November 6, 2025 in Killeen, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 6, 2025
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Killeen, TX (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 98 | 21 CFR 606.100(c) | Thorough investigations |